Following the firm’s $1.75bn acquisition of radiopharmaceuticals company Mariana Oncology and the $745m deal with Ratio ...

The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.

Pluri has announced the issuance of a patent by the US Patent and Trademark Office (USPTO) for its immune cell expansion ...

Belief BioMed (BBM) and Takeda China have announced the receipt of China’s NMPA approval for BBM-H901for treating haemophilia ...

Biocon Biologics has received approval from the US Food and Drug Administration for the intravenous use of Jobevne ...

AI tools are faster at drafting clinical trial documents, but human writers remain indispensable for logical reasoning.

On 7 April, at the 2025 American Academy of Neurology (AAN) meeting, a poster presentation by the Peking Union Medical ...

The UK's MHRA has been redesignated as one of the WHO’s collaborating centres for the standardisation and evaluation of ...

The biotech has launched a strategic review to consider options, including a possible sale, following shareholder pressure.

PharmaLogic is set to acquire a majority stake in Agilera Pharma to generate the CDMO focusing on radiopharmaceutical ...